Veracyte Inc
Veracyte Inc (VCYT) Implied Volatility Current
VCYT implied volatility is 68%. IV Rank is 56%, placing current premiums in the middle of their 52-week range.
Read more
Tracking VCYT implied volatility helps you identify when options premiums on Veracyte Inc are historically cheap or expensive, and where the best trades are hiding. Veracyte Inc implied volatility reflects the market's expectation of future price movement: when VCYT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Veracyte Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For VCYT, tracking metrics like VCYT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on VCYT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis.
It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where VCYT implied volatility sits today versus where it has been. Our scanner ranks Veracyte Inc implied volatility against its historical range, surfaces extremes in VCYT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Veracyte Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is slightly elevated - premiums are richer, leaning toward sellers.
As of September 24, 2026
Trade options with IV on your side
Track VCYT IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→